| P2093 | author name string | Zitzelsberger H | |
| | Schmid C | |
| | Kolb HJ | |
| | Schweiger C | |
| | Pelka-Fleischer R | |
| | Salem A | |
| | Nuessler V | |
| | Kroell T | |
| | de Valle F | |
| | Kufner S | |
| | Schmetzer HM | |
| P2860 | cites work | Immunological weapons against acute myeloid leukaemia | Q34842175 |
| | Dendritic cells in vaccination therapies of malignant diseases | Q34913813 |
| | Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods | Q34926682 |
| | Progressive differentiation and selection of the fittest in the immune response | Q35014086 |
| | The use of dendritic cells in cancer immunotherapy | Q35084257 |
| | Dendritic cells: On the move from bench to bedside | Q40699456 |
| | The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers | Q40712532 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells | Q43719451 |
| | Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells | Q43782922 |
| | Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets | Q44083646 |
| | 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia | Q44281592 |
| | Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors | Q44394548 |
| | Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation | Q47979833 |
| | Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation. | Q50987260 |
| | New targets for therapy in acute myeloid leukemia. | Q53381617 |
| | Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. | Q53398579 |
| | Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients. | Q54057320 |
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| | leukemia | Q29496 |
| P304 | page(s) | 86-98 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. | |
| P478 | volume | 62 | |